Andrew Turitz, EVP, CORPORATE DEVELOPMENT at Teladoc Health, Inc. (TDOC), sold 12,855 shares at $14.52 ($187K) on 2024-03-04, disclosed to the SEC on 2024-03-05.
Scheduled sale ($187k) by EVP, CORPORATE DEVELOPMENT under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.06 | 475 | $7K | 3.8% |
| 2 | $14.52 | 6,190 | $90K | 48.1% |
| 3 | $14.52 | 6,190 | $90K | 48.1% |
| Total | $14.54 avg | 12,855 | $187K | 100% |
| Filing → |
| TDOC | SELL | 2024-06-04 | $18K | — | Filing → |
| TDOC | SELL | 2024-03-06 | $164K | — | Filing → |
| TDOC | SELL | 2023-12-05 | $8K | — | Filing → |